Analyst Downgrades – Hologic (NASDAQ:HOLX) Stock Gets Downgraded By Goldman Sachs Group, Inc. (The) from Conviction-Buy to Buy

ME Staff
-
0

Analyst Ratings For Hologic (NASDAQ:HOLX)

Today, Hologic (NASDAQ:HOLX) stock was downgraded by Goldman Sachs Group, Inc. (The) from Conviction-Buy to Buy.

There are 3 hold ratings, 10 buy ratings on the stock.

The current consensus rating on Hologic (NASDAQ:HOLX) is Buy (Score: 2.77) with a consensus target price of $48.83 per share, a potential 11.82% upside.

Some recent analyst ratings include

  • 8/3/2017-Goldman Sachs Group, Inc. (The) was Downgraded by analysts at Goldman Sachs Group, Inc. (The) from a “Conviction-Buy ” rating to a ” Buy” rating.
  • 8/1/2017-Needham & Company LLC Reiterated Rating of Buy.
  • 7/21/2017-Bank of America Corporation Reiterated Rating of Neutral.
  • 7/17/2017-Barclays PLC Reiterated Rating of Overweight.
  • 7/14/2017-Piper Jaffray Companies Reiterated Rating of Buy.
  • 7/14/2017-Stifel Nicolaus Reiterated Rating of Buy.

Recent Insider Trading Activity For Hologic (NASDAQ:HOLX)
Hologic (NASDAQ:HOLX) has insider ownership of 0.79% and institutional ownership of 94.32%.

  • On 7/17/2017 Karleen Marie Oberton, VP, sold 4,704 with an average share price of $45.19 per share and the total transaction amounting to $212,573.76. View SEC Filing
  • On 7/3/2017 Elaine Ullian, Director, sold 8,849 with an average share price of $45.28 per share and the total transaction amounting to $400,682.72. View SEC Filing
  • On 6/7/2017 Lawrence M Levy, Director, sold 2,960 with an average share price of $44.54 per share and the total transaction amounting to $131,838.40. View SEC Filing
  • On 6/2/2017 Elaine Ullian, Director, sold 8,938 with an average share price of $43.99 per share and the total transaction amounting to $393,182.62. View SEC Filing
  • On 5/30/2017 Peter J Valenti III, Insider, sold 10,005 with an average share price of $43.44 per share and the total transaction amounting to $434,617.20. View SEC Filing
  • On 5/24/2017 Lawrence M Levy, Director, sold 9,193 with an average share price of $42.93 per share and the total transaction amounting to $394,655.49. View SEC Filing
  • On 5/17/2017 Lawrence M Levy, Director, sold 9,076 with an average share price of $42.80 per share and the total transaction amounting to $388,452.80. View SEC Filing

Recent Trading Activity for Hologic (NASDAQ:HOLX)
Shares of Hologic closed the previous trading session at 43.67 down -0.33 -0.75% with 6,896,682 shares trading hands.